Trial Profile
Efficacy and tolerability of Privigen, a polyvalent human IgG preparation, in patients with primary and secondary immunodeficiency-disorders: A German multicentre experience
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Immunodeficiency disorders
- Focus Therapeutic Use
- 15 Dec 2015 New trial record